Allergan Wins Just $48.5K At Trial Over Imprimis False Ads
A California federal jury on Thursday ordered Imprimis Pharmaceuticals to pony up just $48,500 to competitor Allergan after finding the compound drug company cost Allergan business by using false advertisements to...To view the full article, register now.
Already a subscriber? Click here to view full article